• Home
  • About Us
  • Services
  • Portfolio & Cases
  • FAQ
  • Contact
  • More
    • Home
    • About Us
    • Services
    • Portfolio & Cases
    • FAQ
    • Contact
  • Home
  • About Us
  • Services
  • Portfolio & Cases
  • FAQ
  • Contact

smeriglio holdings inc

smeriglio holdings incsmeriglio holdings incsmeriglio holdings inc

Rx Consulting & Capital

Rx Consulting & CapitalRx Consulting & Capital

Some of our Consulting Work via Case Study

Case 1 - Behaviour drivers

Case 2 - Launching in Neurology

Case 2 - Launching in Neurology

  • Situation - One of the LPs required some quant and qual research to understand prescribing accelerators and decelerators of medicinal cannabis in a certain neurodegenerative disorder
  • Target - Specialist nurses
  • Approach - we undertook a cost effective phone based interview amongst the Target, sponsor blinded
  • Outcome - laid a solid foundation for understanding of Rx accelerators and decelerators to help efficiently structure future marketing approach

Case 2 - Launching in Neurology

Case 2 - Launching in Neurology

Case 2 - Launching in Neurology

  • Situation - A large cap Biotech Client was entering a new therapeutic area in which no institutional knowledge existed
  • Target - Specialist KOL physicians, nurses, and community specialists
  • Approach - our group was retained to work on the multi year pre launch and launch as we had extensive national KOL contacts and expertise in this therapeutic area. We developed and implemented, over several years, a layered and progressively building series of Consultant Meetings 
  • Outcome - our approach was a key factor in building advocacy and accelerating prescriptions at launch 

Case 3 - USA Hematology Launch

Case 2 - Launching in Neurology

Case 4 - Evidence-based Analysis

  • Situation - A small, niche Pharma client was launching a rare disorder drug in the USA with a very poor label, missing many salient evidence sets (survival data) supporting the brand and messaging
  • Target - Specialist KOLs and nurses
  • Approach - A series of progressively building advisory boards used as a compliant platform to help share and discuss clinically relevant data that fell outside of the approved label
  • Outcome - increased and accelerated brand uptake due to greater understanding of the risks and more notably, benefits of the client's therapy 

Case 4 - Evidence-based Analysis

Case 6 - Established Cancer Brand

Case 4 - Evidence-based Analysis

  • Situation - A large cap Biotech Client was entering a new space where no institutional knowledge existed and wanted to get an early understanding and foundation of the competitive sets of established rivals
  • Target - N/A
  • Approach - Our group developed an evidence-based review of the medical literature supporting the brand organized in a P.I.C.O.S format as well as CDR / Provincial reimbursement criteria
  • Outcome - these materials helped identify the Client's potential competitive differentiation in the marketplace and are used amongst multiple stakeholders for commercial, training, and medical education purposes.

Case 5 - KOL Digital Portal

Case 6 - Established Cancer Brand

Case 6 - Established Cancer Brand

  • Situation - Our large cap Biotech Client has a brand in a highly competitive space and wanted a means to continue the dialogue with their KOLs who form their advisory board
  • Target - Specialist KOLs and nurses
  • Approach - We developed a super-easy digital portal that was used by the Target at regular intervals post advisory board meeting as a vehicle to stay top of mind and obtain continuous feedback
  • Outcome - We achieved almost 100% participation rate amongst the Target and developed deeper relationships and insights into the behaviours driving brand prescriptions and loyalty

Case 6 - Established Cancer Brand

Case 6 - Established Cancer Brand

Case 6 - Established Cancer Brand

  • Situation - A large cap Biotech Client with a mature oncology brand where the delivery of care was heterogeneous with some centers not following the latest published treatment guidelines, where the Client's brand was an important part of the treatment regimen
  • Target - Specialist KOL physicians
  • Approach - We used a number of regional advisory boards, leveraging peer-to-peer influence, to work towards homogenizing treatment protocols across centres and leveraging evidence-based treatment guidelines
  • Outcome - the regional peer-to-peer programs influenced the modernization of treatment protocols at a local level, resulting in increased utilization of the Client's brand

Contact Us

We are happy to provide additional cases and/or detail. Call or write today!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Copyright © 2025 smeriglio holdings inc - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept